Call your doctor for medical advice about side effects
Preparations
5mg, 10mg, 15mg and 30mg tablets 10mg and 15mg orodispersible tablets 1mg/1ml oral solution 7
4 years; range: 56 to 99 years), the adverse reactions that were reported at an incidence of ≥3% and aripiprazole incidence at least twice that for placebo were lethargy [placebo 2% May 16, 2023 · Aripiprazole is a medication used to manage and treat schizophrenia, mania associated with bipolar I disorder, irritability associated with an autism spectrum disorder, disjunctive therapy in major depressive disorder, and Tourette syndrome
The empirical formula is C 23 H 27 C 12 N 3 O 2 and its molecular weight is 448
Generic name: aripiprazole (oral) [ AR-i-PIP-ra-zole ] Brand name: Abilify
Swallow your tablet with a drink of
It can take several days or even weeks for some of your symptoms to start to get better
Aripiprazole can cause
About aripiprazole
Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation
Aripiprazole 1 mg/ml oral solution is a clear, colourless liquid supplied in amber glass bottles containing 150 ml per bottle
To do so may increase the chance of side effects
Aripiprazole 5mg tablets are a medication for treating schizophrenia, bipolar disorder and other mental health conditions
If fluid-restricted, can be given undiluted through central venous catheter [unlicensed]
How to take Aripiprazole Oral Solution 4
To allow the start of the treatment at a low dose you can use an alternative formulation (oral solution – liquid) more suitable than Aripiprazole Sandoz tablets
Most of the deaths were linked to heart disease or infection
How and when to take it
Aripiprazole is effective in a dose range of 10 to 30 mg/day
Aripiprazole can also be used for children with severe autism
Before treatment initiation risperidone-naïve patients should be titrated with oral risperidone for at least 14 days; patients stabilised on other oral antipsychotics, but with previous response to risperidone, should be titrated with oral
ABILIFY 1 mg/mL oral solution is a clear, colourless to light yellow liquid supplied in bottles with polypropylene child-resistant closure containing 50 mL, 150 mL or 480 mL per bottle
5 mg up to twice weekly, adjusted according to response; usual dose 25–37